USPTO 2015–2025 USPTO PatentsView US Corporation

Vyaire Medical, Inc.

USPTO PatentsView assignee record - 32 granted patents across 12 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vyaire ranks #9,928 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 12 technology areas.

#9,928
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.5/100)
5.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R9928 · US Corporation #9,928 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 32 grants
  • UPPER-Q #9,928/49,997
  • PHOTO-FINISH Verdant Robotics
  • CPC-FOCUS A61B · 12 areas
  • INNOV-THIN 35.5/100
  • CLAIMS-SPARSE 5.2 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Verdant Robotics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vyaire’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Vyaire

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vyaire's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Vyaire?

Each dot is one of Vyaire’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vyaire’s own 5.2 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vyaire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 31.932.032.03232.032.032.1 0510152025 Granted patents (volume) Avg claims / patent Verdant Robotics, Inc. - 32, 23.34Verdant RoboticsVerizon and Redbox Digital Entertainment Services, LLC - 32, 20.06Verizon and Redbo…Vilnius University - 32, 18.28Vilnius UniversityVulcan Industrial Holdings, LLC - 32, 15.91Vulcan Industrial…Wave Life Sciences Ltd. - 32, 21.72Wave Life SciencesWebasto-edscha Cabrio GMBH - 32, 10.91Webasto-edscha Ca…WET - 32, 13.62WETWeatherford U.K. Limited - 32, 19.53Weatherford U KVyaire Medical, Inc. - 32, 5.19Vyaire Medical
Vyaire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vyaire's grants concentrate

Vyaire Medical, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 18.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (12 grants) versus a trough of 2 in 2020. By volume, Vyaire sits between Verdant Robotics, Inc. and Weatherford U.K. Limited.

Vyaire's three-year grant acceleration

Vyaire Medical, Inc. shows 17 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Vyaire's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Vyaire holds 32 patents at rank #9,927, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vyaire

By rank, the assignees closest to #9,927 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Vyaire's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vyaire, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Vyaire ranks #2,680 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Vyaire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 202020212022202320242025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Vyaire Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 6.3%
2021 12 37.5%
2022 6 18.8%
2023 8 25.0%
2024 3 9.4%
2025partial year 1 3.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Vyaire Medical, Inc.'s patent record in context - here's where to go next.

  • Vyaire Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 18.8% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #9,928 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Vyaire Medical, Inc. against Verdant Robotics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.